ArticleEmerging microbes & infections2021

Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.

Shan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.